These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28071741)

  • 1. Loss of Coupling Distinguishes GJB1 Mutations Associated with CNS Manifestations of CMT1X from Those Without CNS Manifestations.
    Abrams CK; Goman M; Wong S; Scherer SS; Kleopa KA; Peinado A; Freidin MM
    Sci Rep; 2017 Jan; 7():40166. PubMed ID: 28071741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GJB1-associated X-linked Charcot-Marie-Tooth disease, a disorder affecting the central and peripheral nervous systems.
    Abrams CK; Freidin M
    Cell Tissue Res; 2015 Jun; 360(3):659-73. PubMed ID: 25370202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic inflammation disrupts oligodendrocyte gap junctions and induces ER stress in a model of CNS manifestations of X-linked Charcot-Marie-Tooth disease.
    Olympiou M; Sargiannidou I; Markoullis K; Karaiskos C; Kagiava A; Kyriakoudi S; Abrams CK; Kleopa KA
    Acta Neuropathol Commun; 2016 Sep; 4(1):95. PubMed ID: 27585976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular mechanisms of connexin32 mutations associated with CNS manifestations.
    Kleopa KA; Yum SW; Scherer SS
    J Neurosci Res; 2002 Jun; 68(5):522-34. PubMed ID: 12111842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal gene therapy in mouse models expressing CMT1X mutations.
    Kagiava A; Karaiskos C; Richter J; Tryfonos C; Lapathitis G; Sargiannidou I; Christodoulou C; Kleopa KA
    Hum Mol Genet; 2018 Apr; 27(8):1460-1473. PubMed ID: 29462293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A start codon CMT1X mutation associated with transient encephalomyelitis causes complete loss of Cx32.
    Sargiannidou I; Kim GH; Kyriakoudi S; Eun BL; Kleopa KA
    Neurogenetics; 2015 Jul; 16(3):193-200. PubMed ID: 25771809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects.
    Sargiannidou I; Vavlitou N; Aristodemou S; Hadjisavvas A; Kyriacou K; Scherer SS; Kleopa KA
    J Neurosci; 2009 Apr; 29(15):4736-49. PubMed ID: 19369543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GJB1 mutations c.212T>G and c.311A>C induce apoptosis and inwardly rectifying potassium current changes in X-linked Charcot-Marie-Tooth type 1.
    Guo H; Liu Y; Gu J; Luo J; Ma Y; Xiao F
    Biochem Biophys Res Commun; 2021 Dec; 582():8-15. PubMed ID: 34678594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetics of X-linked Charcot-Marie-Tooth disease.
    Kleopa KA; Scherer SS
    Neuromolecular Med; 2006; 8(1-2):107-22. PubMed ID: 16775370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central visual, acoustic, and motor pathway involvement in a Charcot-Marie-Tooth family with an Asn205Ser mutation in the connexin 32 gene.
    Bähr M; Andres F; Timmerman V; Nelis ME; Van Broeckhoven C; Dichgans J
    J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):202-6. PubMed ID: 10071100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Golgi-retained Cx32 mutants interfere with gene addition therapy for CMT1X.
    Kyriakoudi S; Sargiannidou I; Kagiava A; Olympiou M; Kleopa KA
    Hum Mol Genet; 2017 May; 26(9):1622-1633. PubMed ID: 28334782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connexins, gap junctions and peripheral neuropathy.
    Kleopa KA; Sargiannidou I
    Neurosci Lett; 2015 Jun; 596():27-32. PubMed ID: 25449862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Genetic Features of Chinese X-linked Charcot-Marie-Tooth Type 1 Disease.
    Lu YY; Lyu H; Jin SQ; Zuo YH; Liu J; Wang ZX; Zhang W; Yuan Y
    Chin Med J (Engl); 2017 May; 130(9):1049-1054. PubMed ID: 28469099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four novel connexin 32 mutations in X-linked Charcot-Marie-Tooth disease. Phenotypic variability and central nervous system involvement.
    Karadima G; Koutsis G; Raftopoulou M; Floroskufi P; Karletidi KM; Panas M
    J Neurol Sci; 2014 Jun; 341(1-2):158-61. PubMed ID: 24768312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked Charcot-Marie-Tooth disease.
    Scherer SS; Kleopa KA
    J Peripher Nerv Syst; 2012 Dec; 17 Suppl 3(0 3):9-13. PubMed ID: 23279425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of X-linked Charcot-Marie-Tooth disease: differential effects of two mutations in connexin 32.
    Abrams CK; Freidin M; Bukauskas F; Dobrenis K; Bargiello TA; Verselis VK; Bennett MV; Chen L; Sahenk Z
    J Neurosci; 2003 Nov; 23(33):10548-58. PubMed ID: 14627639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease?
    Kleopa KA; Abrams CK; Scherer SS
    Brain Res; 2012 Dec; 1487():198-205. PubMed ID: 22771394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked Charcot-Marie-Tooth type 1: stroke-like presentation of a novel GJB1 mutation.
    Sagnelli A; Piscosquito G; Chiapparini L; Ciano C; Salsano E; Saveri P; Milani M; Taroni F; Pareyson D
    J Peripher Nerv Syst; 2014 Jun; 19(2):183-6. PubMed ID: 24863494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraneural GJB1 gene delivery improves nerve pathology in a model of X-linked Charcot-Marie-Tooth disease.
    Sargiannidou I; Kagiava A; Bashiardes S; Richter J; Christodoulou C; Scherer SS; Kleopa KA
    Ann Neurol; 2015 Aug; 78(2):303-16. PubMed ID: 26010264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and cellular expression of two novel connexin32 mutations causing CMT1X.
    Kleopa KA; Zamba-Papanicolaou E; Alevra X; Nicolaou P; Georgiou DM; Hadjisavvas A; Kyriakides T; Christodoulou K
    Neurology; 2006 Feb; 66(3):396-402. PubMed ID: 16476939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.